Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System
Aisling R Caffrey, Haley J Appaneal, Vrishali V Lopes, Laura Puzniak, Evan J Zasowski, Luis Jodar, Kerry L LaPlante, John M McLaughlin · 2024
Read Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System by Aisling R Caffrey, Haley J Appaneal, Vrishali V Lopes, Laura Puzniak, Evan J Zasowski, Luis Jodar, Kerry L LaPlante, John M McLaughlin (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11531596.txt.
Description
Data evaluating effectiveness of XBB.1.5-adapted vaccines against JN.1-related endpoints are scarce. This nationwide test-negative case-control study within the US Veterans Affairs Healthcare System aims to estimate vaccine effectiveness (VE) of BNT162b2 XBB.1.5-adapted vaccine compared to not receiving an XBB vaccine of any kind against COVID-19 hospitalization, emergency department or urgent care visits (ED/UC), and outpatient visits.
Catalog record
| CREATOR | Aisling R Caffrey, Haley J Appaneal, Vrishali V Lopes, Laura Puzniak, Evan J Zasowski, Luis Jodar, Kerry L LaPlante, John M McLaughlin |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |